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RÉSUMÉ 
Le but d'un traitement antimicrobien est d'éradiquer une infection bactérienne. Cependant, il 
est souvent difficile d'en évaluer rapidement l'efficacité en utilisant les techniques standard. 
L'estimation de la viabilité bactérienne par marqueurs moléculaires permettrait d'accélérer le 
processus. Ce travail étudie donc la possibilité d'utiliser le RNA ribosomal (rRNA) à cet effet. 
Des cultures de Streptococcus gordonii sensibles (parent Wt) et tolérants (mutant Toll) à 
l'action bactéricide de la pénicilline ont été exposées à différents antibiotiques. La survie 
bactérienne au cours du temps a été déterminée en comparant deux méthodes. La méthode de 
référence par compte viable a été comparée à une méthode moléculaire consistant à amplifier 
par PCR quantitative en temps réel une partie du génome bactérien. La cible choisie devait 
---~ref1Mei:-la-Viabilité-cellulaire_eLpar_conséquenl.füre_synthétisée de manière constitutive lors de 
la vie de la bactérie et être détruite rapidement lors de la mort cellulaire. Le choix s'est porté 
sur un fragment du gène 16S-rRNA. 
Ce travail a permis de valider ce choix en corrélant ce marqueur moléculaire à la viabilité 
bactérienne au cours d'un traitement antibiotique bactéricide. De manière attendue, les S. 
gordonii sensibles à la pénicilline ont perdu ~ 4 log10 CFU/ml après 48 heures de traitement 
par pénicilline alors que le mutant tolérant Toll en a perdu :::; 1 log1 0 CFU/ml. De manière 
intéressant, la quantité de marqueur a augmenté proportionnellement au compte viable durant 
la phase de croissance bactérienne. Après administration du traitement antibiotique, 
l'évolution du marqueur dépendait de la capacité de la bactérie à survivre à l'action de 
l'antibiotique. Stable lors du traitement des souches tolérantes, la quantité de marqueur 
détectée diminuait de manière proportionnelle au compte viable lors du traitement des souches 
sensibles. Cette corrélation s'est confirmée lors de l'utilisation d'autres antibiotiques 
bactéricides. 
En conclusion, l'amplification par PCR du RNA ribosomal 16S permet d'évaluer rapidement 
la viabilité bactérienne au cours d'un traitement antibiotique en évitant le recours à la mise en 
culture dont les résultats ne sont obtenus qu'après plus de 24 heures. Cette méthode offre donc 
au clinicien une évaluation rapide de l'efficacité du traitement, particulièrement dans les 
situations, comme le choc septique, où l'initiation sans délai d'un traitement efficace est une 
des conditions essentielles du succès thérapeutique. 
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INTRODUCTION 
Classical techniques to identify bacterial pathogens include phenotyping of live bacteria, 
specific immunostaining, and indirect measurement of the host's serologic response. However, 
cultures can remain negative in the case of fastidious organisms or after antibiotic 
administration. Immunostaining is not always specific and is highly dependent on sampling. 
And serology provides a delayed diagnostic answer and can also lack specificity. 
Recent molecular methods may help circumvent some of these limitations. They are 
aimed at detecting either proteins or nucleic acids by direct molecular probing, or by 
amplifying specific determinants such as the ribosomal RNA genes (rDNA) by polymerase-
chain reaction (PCR) (1, 5, 12-14, 25-27, 35). They play an important role in the case of 
culture-negative infections (3, 13, 14). Moreover, they yield results within hours as compared 
to days or sometimes weeks with conventional phenotypic techniques. Y et, none of these 
methods provide information on the viability of the infecting microorganisms. 
Determination of bacterial viability is critical to follow the bactericidal activity of 
antibiotics in vitro and in vivo, as well as to assess the presence of viable pathogens in 
contaminated food or environmental samples (2, 13, 20, 21, 24). Molecular markers of 
viability might be useful to follow microbiological cure in a variety of clinical situations, and 
to rapidly appraise drug efficacy. In this regard, notoriously problematic pathogens include 
Mycobacterium tuberculosis and Mycobacterium leprae, for which determining drug-induced 
killing by standard techniques takes between weeks and months (18, 30, 38). 
Several physiological and molecular reporters of viability have been explored. These 
include measurement of cellular integrity ( e.g. by vital staining), measurement of metabolic 
activities ( e.g. active electron transport chain, transport of glucose, esterase activity), 
measurement of synthetic activities (e.g. polymer synthesis and cell elongation) (37), and 
molecular probing or amplification of DNA, mRNA and 16S rRNA (20). DNA amplification 
appeared particularly unreliable because it can remain positive for extensive periods of time, 
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ABSTRACT 
Assessing bacterial viability by molecular markers might help accelerate the measurement of 
antibiotic-induced killing. This study investigated whether ribosomal RNA (rRNA) could be 
suitable for this purpose. Cultures of penicillin-susceptible and penicillin-tolerant (Toll 
mutant) Streptococcus gordonii were exposed to mechanistically different penicillin and 
levofloxacin. Bacterial survival was assessed by viable counts, and compared to quantitative 
real-time PCR amplification of either the 16S-rRNA genes (rDNA) or the 16S rRNA, 
following reverse transcription. Penicillin-susceptible S. gordonii lost ~ 4 log10 CFU/ml of 
viability over 48 h of penicillin treatment. In comparison, the Toll mutant lost :::; 1 log10 
CFU/ml. Amplification of a 427-base fragment of 16S rDNA yielded amplicons that increased 
proportionally to viable counts during bacterial growth, but did not decrease during drug-
induced killing. In contrast, the same 427-base fragment amplified from 16S rRNA paralleled 
both bacterial growth and drug-induced killing. It also differentiated between penicillin-
induced killing of the parent and the Toll mutant(~ 4 log10 CFU/ml and:::; 1 log10 CFU/ml, 
respectively), and detected killing by mechanistically unrelated levofloxacin. Since large 
fragments of polynucleotides might be degraded faster than smaller fragments the experiments 
were repeated by amplifying a 119-base region internal to the original 427-base fragment. The 
amount of 119-base amplicons increased proportionally to viability during growth, but 
remained stable during drug treatment. Thus, 16S rRNA was a marker of antibiotic-induced 
killing, but the size of the amplified fragment was critical to differentiate between live and 
dead bacteria. 
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in spite of effective bacterial killing (4, 7, 15, 16, 19-21, 28, 29, 34, 36, 37). In addition, most 
other methods provided con:flicting results that varied depending on the experimental 
conditions, including whether bacteria were killed by antibacterial drugs (15, 20, 36) or by 
physical means ( e.g. heat and UV irradiation) (24, 31, 37). Thus, there are currently no 
reliable molecular tools for routine determination of cell viability and drug-induced killing in 
medical microbiology. 
The present experiments explored the correlation between bacterial viability ·and the 
number of copies of 16S rRNA - as determined by reverse transcription followed by 
quantitative real-time PCR - during bacterial growth and antibiotic-induced killing of 
Streptococcus gordonii. This organism was used as a model because it is poorly lysed by 
penicillin and provides a well described isogenic pair of kill-susceptible (parent) and kill-
resistant (tolerant mutant Toll) strains (6, 22). Studied were performed with two 
mechanistically umelated compounds, i.e. penicillin G and the quinolone levofloxacin. A 
specific fragment of 16S rRNA of a specific size appeared suitable to quantify drug-induced 
killing. 
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MATERIALS AND METHODS 
Microorganisms and growth conditions. A described streptomycin-resistant S. gordonii 
Challis and its penicillin-tolerant mutant Toll were used as model organisms (6, 22). 
Streptococci were grown at 37°C without aeration either in brain heart infusion (BHI; Difco 
laboratories, Detroit, MI) supplemented with 200 mg/liter of streptomycin (in order to respect 
the experimental conditions in which these isolates were described)(6, 22), or on Columbia 
agar (Becton Dickinson Microbiology Systems, Cockeysville, MD) supplemented with 3% 
blood. Escherichia coli XL-1 blue were grown at 37°C in Luria Bertani broth (LB, Difco) or 
on LB agar (Difco ), supplemented with 50 mg/liter of ampicillin (Sigma Chemicals ). Stocks 
were stored at -70°C in culture medium supplemented with 10% (vol/vol) glycerol. Bacterial 
growth was followed by optical density at a wavelength of 620 nm (OD620) with a 
spectrophotometer (Sequoia-Turner, Montainville, CA), and by colony count on agar plates. 
When appropriate, penicillin G (Hoechst-Pharma, Zurich, Switzerland) and levofloxacin 
(A ventis Pharma Ltd., Romainville, France) were added to the medium at final concentrations 
of 2 mg/liter and 12.5 mg/liter, respectively, mimicking high-dose treatment in human. The 
minimal inhibitory concentrations of these antibacterials for the test bacteria were 0.004 and 
0.5 mg/liter (6, 11). 
Antibiotics and chemicals. Streptomycin was purchased from Sigma AG (Buchs, 
Switzerland), penicillin G from Hoechst-Pharma AG (Zurich, Switzerland) and levofloxacin 
from A ventis Pharma Ltd. (Romainville, France). The restriction enzymes (Boehringer 
Mannheim, Germany), Taq DNA polymerase (Gibco BRL, Gaithersburg, MD) and T4 DNA 
ligase (Gibco) were used according to the manufacturer's recommendations. Nucleic acid 
sequencing and synthesis was performed by Microsynth GmbH (Balgach, Switzerland). All 
other chemicals were reagent-grade, commercially available products. 
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Antibiotic susceptibility and time-kill curves. The MICs were determined by standard 
macrodilution methods (32). Time-kill curves were determined by adding appropriate 
concentrations of antibiotics to bacterial cultures in the exponential phase of growth at an 
OD62o of 0.2 (6, 22). At various time points before and after drug addition, samples were 
removed and processed (i) for viable count, (ii) for DNA extraction and (iii) for RNA 
extraction. For viable count, antibiotic carryover on the agar plates was avoided as described 
previously (10, 11). Colonies were counted after 48 h of incubation at 37°C. DNA was 
extracted from frozen culture samples kept at -70°C, whereas RNA was isolated directly from 
fresh samples. 
DNA extraction and purification. Total DNA from 3 ml of culture samples was extracted 
and purified using the DNeasy Tissue Kit according to the manufacturer's instructions 
(Qiagen GmbH, Hilden, Germany). Lysis of streptococci was performed as follows. Samples 
were centrifuged at 14'000 rpm for 15 min at 4°C. Pellets were washed two times with NaCl 
0.9% and resuspended in 220 µl buffer [Tris-Hel 20 mM pH 8.0, EDTA 5 mM, 25% sucrase 
and 17 µg/ml of lysozyme (Sigma)]. The samples were then incubated for 30 min at 37°C, 
before the addition of 200 µl of lysis buffer (Buffer AL, Qiagen) supplemented with final 
concentrations of 0.2% of SDS (Sigma) and 1 mg/ml of proteinase K (Sigma). After an 
additional 30 min incubation at 70°C, DNA was purified according to the standard protocol 
(Qiagen), resuspended in a 200 µl final volume and kept frozen at -20°C0 • Input volumes for 
further amplification consisted in 1 µl aliquots of the stored samples. 
RNA extraction and purification. For total RNA purification, 9 ml of fresh culture samples 
were centrifuged at 10'000 rpm for 8 min at 4°C and processed according to the FastRNA 
BLUE Protocol of BIO 101 (Bio 101 Inc., La Jolla, CA) modified as follows. Bacterial pellets 
were resuspended in 500 µl of CRSR-BLUE reagent and transferred into tubes containing 
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ceramic beads, supplemented with 500 µl of phenol acid reagent (PAR) and 1 OO µl of a 
solution of 24: 1 chloroform-isoamyl alcohol (CIA). The samples were further processed at 
4°C using a FastPrep FP120 apparatus (Bio 101, Savant Instruments, Inc. Holbrook, NY) for 
25 sec at a speed of 6.5 mis, before being centrifuged at 14'000 rpm for 10 min. The aqueous 
phase was collected and added to a 500 µl of the CIA solution. The samples were then 
centrifuged at 14'000 rpm for 5 min. The aqueous phase was collected and mixed with 350 µl 
ofRLT Buffer (RNeasy Mini Kit, Qiagen) supplemented with 1 % P-Mercaptoethanol and 250 
µl RNase-free Ethanol (96-100%). Total RNA was further purified according to the standard 
RNase-Free DNase Set Protocol of Qiagen, resuspended in a 50 µl final volume and kept 
frozen at -80 C0 • Input volumes for further amplification consisted in 5 µl aliquots of the 
stored samples. 
The yield of RNA was quantified in each experiment by absorbance at 260 nm 
(Biophotometer Thermostat Plus, Eppendorf AG, Germany). As an additional control, the 
presence of rRNA in the extracts was qualitatively assessed by electrophoresis and ethidium 
bromide staining on a 1.2% agarose-0.66 M formaldehyde gel in morpholinepropanesulfonic 
acid running buffer (Sigma), next to a molecular weight ladder. 
Construction of molecular standards for quantitative real-time PCR. To build standard 
curves for both real-time PCR and RT-PCR it was important to first generate control 
molecules with known molar concentrations. First, a DNA standard was generated by cloning 
the PCR product corresponding to the 427-base fragment of the 16S rDNA of S. gordonii into 
the pGemT-Easy vector system (Promega Corporation, Madison, Wis.) according to the 
manufacturer's instructions and transformed in Escherichia coli by the standard technique. 
Effective amplicon ligation by T4 DNA ligase (Gibco BRL, Gaithersburg, Md.) was verified 
by standard restriction enzymes, amplification was performed by using the Wizard Midiprep 
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UI of Taq DNA Polymerase (Life Technologies AG). Amplification was performed for 25 
cycles at the following conditions: 94°C for 30 sec, 50°C for 30 sec and 72°C for 20 sec. 
Quantities of polynucleotides were assessed on ethidium bromide containing 1 % agarose gel 
using standard techniques scanning densitometry at a wavelength of 280 using the EagleEye II 
Still Video System and the EagleSight software (Stratagene, La Jolla, CA). 
Reverse-transcriptase amplification. Prior to quantification, reverse-transcriptase (RT) PCR 
was performed on all RNA samples using the Omniscript RT Kit (Qiagen) in a total volume-
reaction of 20 µl according to the manufacturer's instructions. Different solutions containing 
between 102-108 RNA molecules were prepared as above. RT-PCR of test and standard 
samples were run in parallel. Test samples consisted in 20 µl aliquots of the stored materials. 
RT-PCR efficiency was 30% and was calculated as follows: number of molecules of 
cDNA/number of molecules of RNA x 100%. The number of RNA molecules of each 
unknown sample was calculated on the base of both the standard curve (quantitative real-time 
PCR) and the RT-PCR efficiency. Each standard and test samples were run in quintuplicate 
and processed in parallel for further quantification, in order to appraise the intra-experiment 
relative variation. This variation was :::; 20%. The results of the experiments are expressed as 
the mean of values of these quintuplicates. 
Quantitative evaluation by real-time PCR. Determination of l 6S rDNA copy numbers was 
performed using the following probe FAM-5'-TTG CAC CAC TAC CAG ATG GAC CTGC-
3'-TAMRA (nucleotides 220-244) according to the manufacturer's instructions (Perkin-
Elmer) on a Sequence Detection System 5700 (Perkin-Elmer). The fragment 88-514 (427-
base) of 16S rDNA was amplified using the above described primer pair. In certain 
experiments a shorter 119-base interna! portion of the 427-base fragments was amplified 
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( corresponding to nucleotides 158-276 of the S. gordonii 16S rDNA), using the primers 5'-
GGA AAC GAT AGC TAA TAC CGC ATAA-3' and 5'-AAT CGA TCA TCC ACT CCA 
TTG CCG AG-3'. Reactions were started on a Sequence Detection System 5700 (Perkin-
Elmer) in a total volume of 50 µl lx PCR buffer (Gibco) containing 0.5 µM of each primer, 
120 nM of fluorescent probe, 0.3 mM of each dNTP, 2.5 mM MgCh and 1.5 UI of Taq DNA 
polymerase (Life Technologies). The following program was applied during 40 cycles: 94°C 
for 15 sec, 52°C for 30 sec, and 72°C for 30 sec. Each experiment was clone in triplicate. 
The yield of real-time PCR was assessed by plotting the Ct values versus the log10 
numbers of input DNA copies. In a typical experiment (6 parallel runs for each sample), the 
mean slopes of the plots were (Mean± SD) -3.56 ± 0.1 for the 119 bp fragment and 3.9 ± 0.04 
for the 427 bp fragment. This translates into yields of 98.6% and 80.2% for the two fragments, 
respectively. Although these yields were different, they did not affect the interpretation of the 
results because amplicons resulting from the different fragments were not compared between 
the m. 
DNA content of each sample was determined using a standard curve obtained by 
processing, in parallel, samples containing fixed DNA concentrations. Determination of DNA 
concentrations was performed by spectrophotometry, and molar concentration determined 
using the following formula: 1 µg of a 1000 bp DNA fragments = 1.52 pmol = 1.52 10·12 
20 
moles x N molecules, where N stands for the Avogadro number (6.023 x 10 j 
molecules/mole ). Different solutions were then accordingly prepared (108 -102 molecules/µl) 
and used as standard solutions in the further experiments. 
Assessment of drug-induced killing by vital staining. The parent S. gordonii and its Toll 
mutant were treated with penicillin as described. Just before and 24 h after drug addition 
samples (100 µl) were removed from the cultures, washed twice with PBS buffer (by 
Aellen et al 
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centrifugation), and processed both for viable counts and for vital staining according to the 
manufacturer's instructions (Live/Dead® BacLight™, Molecular Probes, Eugene, Oregon, 
USA). In brief, bacterial samples (1 OO µl) were mixed with 0.3 µl of a mixture of equal parts 
of SYTO 9 and propidium iodide and incubated in the dark for 20 min. 2 µl of the stained 
suspension was deposited on a glass slide and covered with a cover slip. Image acquisition 
was performed with a confocal scanning laser microscope (model TCS SL; Leica Lasertechnik 
GmbH, Heidelberg, Germany). Confocal illumination was provided by Ar and HeNe lasers 
( 488-nm and 543-nm laser excitation, respectively). The SYTO 9 signal was collected in the 
range 503-523 nm and the propidium iodide signal between 575 and 630 nm. The sensitivities 
of the photomultipliers and the laser intensity were adjusted and thereafter kept constant 
throughout the experiments. Randomly selected regions of each sample were imaged using an 
x20 oil immersion objective. The area of each section was transformed into a digital image of 
512 by 512 pixels. 
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RESULTS 
Absence of correlation between viable counts, optical density and non-quantitative PCR 
of 16S rDNA. Physically intact bacteria are considered alive if they are able to give rise to a 
progeny. Optical density is a correlate of bacterial mass, but bacteria forming this mass are not 
necessarily alive. Likewise, non-quantitative PCR amplification reveals the presence of 
specific polynucleotides fragments, but non-quantitative detection of polynucleotides 
fragments bears no linear correlation with bacterial mass or viability. Hence, these two 
methods are not likely to be good indicators of bacterial viability. This was confirmed in the 
present experimental setting, as a control (Figure 1 ). Optical density increased proportionally 
to viable counts during bacterial growth (Figure IA). Yet, it barely decreased during penicillin 
treatment, in spite of a viability loss of~ 4 log10 CFU/ml within 48 h of drug exposure (Figure 
IB). Non-quantitative PCR amplification was even less representative of viability. 
Amplification of a 427-base fragment of the 16S rDNA yielded quantities of amplicons that 
had no correlation with either bacterial mass or penicillin-induced killing (Figure 1 ). Thus, 
more precise techniques were needed. 
Limited correlation between viable counts and quantitative real-time PCR of 16S rDNA. 
To improve quantitative assessment we repeated the experiments using real-time PCR. 
Amplification of the same 427-base fragment of the 16 rDNA yielded quantities of amplicons 
that increased proportionally to bacterial mass during logarithmic growth, and stabilized after 
entry into stationary phase (Figure 2). This correlated well with bacterial viability in the non-
treated cultures (Figure 2A), but not with penicillin-induced killing (Figure 2B), as the 
quantities of real-time PCR products remained stable in spite of an extensive loss ofviability 
of ~ 4 Log10 CFU/ml/48 h. Thus, the real-time PCR products were a good correlate of 
bacterial mass, but not of bacterial viability senso strictu. This confirms the good stability of 
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DNA during non-lytic killing of bacteria by antibiotics (4, 7, 15, 16, 19-21, 28, 29, 34, 36, 
37). 
Good correlation between viable counts and quantitative real-time PCR of 16S rRNA. 
We next tested whether RNA would be more sensitive than DNA to monitor drug~induced 
killing. Both messenger RNA (mRNA) and rRNA were potential targets. However, mRNA 
has a very short half life in bacteria. Hence, drugs inhibiting DNA transcription ( e.g. rifampin) 
may result in a rapid drop in mRNA, irrespective to their bacteriostatic or bactericidal effect 
(15). 
rRNA might more appropriate. Therefore we tested the stability of 16S rRNA as a 
potential marker of drug-induced killing. Total RNA was reverse-transcribed and the 
quantities of 16S rRNA were assessed by real-time PCR amplification of the 427-base 
fragment from cDNA. This yielded quantities of amplicons that correlated very closely with 
viable counts during logarithmic growth and stationary phase, and also correlated with drug-
induced killing during penicillin treatment (Figure 3). Moreover, the system could readily 
differentiate between the extensive drug-induced killing of the S. gordonii parent (Figure 3A), 
and the kill-resistance phenotype of mutant Toll (Figure 3B). 
Good correlation between real-time PCR of 16S rRNA and quinolone-induced killing. 
To assess whether degradation of 16S rRNA might also apply to killing by a mechanistically 
different antibiotic we repeated the experiments with the quinolone levofloxacin. Quinolones 
generate breaks in the chromosomal ladder (17, 33), but are not expected to perturb rRNA. 
The stability ofboth the 16S rDNA (Figure 4 A) and the 16S rRNA (Figure 4B) was tested by 
quantitative amplification of the 427-base fragment described above. Killing by levofloxacin 
was fast, as previously reported (Il). Amplification of both rDNA and rRNA paralleled 
bacterial viability during the logarithmic and stationary growth phases. After addition of 
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levofloxacin, the quantities of rDNA amplicons remained remarkably stable, in spite of 
rapid drug-induced killing (> 3 log10 CFU in 6 h)(Figure 4A). In contrast, the quantities of 
l 6S rRNA copies dropped by > 3 log10, thus reflecting the bactericidal effect of the drug 
(Figure 4B). Therefore, quantitative amplification of the 427-base fragment of 16S rRNA 
correlated with killing by bath cell wall inhibitors and DNA gyrase inhibitors. 
Large fragments of rRNA are better markers of drug-induced killing than smaller 
fragments. Since large polynucleotides fragments might be degraded faster than smaller ones 
(23), we repeated the 16S rRNA experiment by amplifying a shorter (119-base) segment 
internai to the 427-base fragment used above (Figure 5). The quantities of 119-base amplicons 
correlated with viable counts during logarithmic growth and stationary phase, but decreased 
only by one order of magnitude (instead of~ 3 orders of magnitude) during penicillin~induced 
killing (Figure 5A). Nevertheless, they still revealed a difference between the kill-susceptible 
parent and the Toll mutant (Figure 5B). Thus, the shorter 119-base fragment was less. optimal 
than the longer 427-base fragment to assess penicillin-induced killing and tolerance. 
Poor correlation between penicillin-induced killing and vital staining. The parent S. 
gordonii and its Toll mutant were exposed to penicillin G as above. Samples were removed 
juts prior and 24 h after drug addition, and processes for bath viable counts and vital staining. 
For each sample, 20 random area continent 100 - 200 bacterial bodies were visually assessed 
by phase contrast microscopy and counted for green (alive) and red (dead) staining. Before 
penicillin addition all bacteria on the slides appeared in short chains of 2-10 cells at phase 
contrast. Accordingly, the number of green/red bacteria counted were 2524/2544 (98%) for 
the parent and 2537/2553 (99%) for the Toll mutant. After 24 h of penicillin treatment, the 
normally-looking organisms decreased by up to 300x in the penicillin-killed parent, as 
opposed to only 20 in the kill-tolerant mutant. Most bacteria appeared as single or double 
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bulged cells, condensed ghost, or intermediate forms. These forms were not stained by the 
BacklightTM system ( dead bacteria should have appeared in red) and thus escaped the 
quantification by vital staining. Among the remaining forms, red/green counts were 670/1165 
(58%) for the parent (in spite of a killing of:::::_ 3 log10 CFU/ml), and 2166/2924 (74%) for the 
Toll mutant, which had lost < 1 log10 CFU/ml. As a control, heat-killed S. gordonii and 
Bacillus subtilis killed by membrane-active agents turned entirely red (data not presented). 
Thus, although combining phase contrast microscopy and vital staining revealed a difference 
between live and antibiotic-killed bacteria, it was less accurate and more difficult to interpret 
than determining the number of copies of rRNA. 
Aellen et al. 
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DISCUSSION 
The present results disclosed a reproducibly good correlation between the loss of viable 
counts and the drop in the quantities of copies yielded by real-time PCR amplification of a 
427-base fragment of the 16S rRNA. Coherent results were obtained with both the parent and 
the tolerant mutant Toll, as well as with mechanistically unrelated penicillin and levo:floxacin, 
provided that a minimal (427-base) fragment length of rRNA was used. A shorter (119-base) 
template was much less reliable in differentiating between live and dead bacteria. 
The experiments support the work by van der Vliet et al. (36), who observed that 
rRNA may be degraded during antibiotic-induced killing of Mycobacterium smegmatis treated 
with rifampin and o:floxacin. However, this pioneer report disclosed only a modest correlation 
between the viability loss and decay in rRNA, which underestimated drug-induced killing by 
> 1 Oüx (36). The present molecular system was much more sensitive and predicted cell death 
in the same order of magnitude as actual killing. The principal difference between these two 
observations may rely on technical issues, one using nucleic acid sequence-based 
amplification (NASBA)(36) and one (presented herein) quantitative real-time PCR. 
On the other hand, both the van der Vliet et al. report (36) and the present experiments 
are different from the results by Hellyer et al. (15), who studied the decrease in mRNA and 
16S rRNA during treatment of M tuberculosis with isoniazid and rifampin. These authors 
observed that cell death was accompanied by a sharp decrease in mRNA, but barely found any 
decrease in 16S rRNA. However, rRNA was detected by sequential reverse transcription and 
non-quantitative PCR amplification of cDNA from a short (160-base) rRNA fragment. This 
approach may have missed degradation of rRNA for at least two reasons. First, amplification 
was not quantitative, and second the length of the rRNA fragment might have been 
suboptimal. 
Both of these issues were critical in the present work. In particular, the inverse relation 
between polynucleotide length and the lack of polynucleotide amplification is supported by 
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earlier reports, for instance during chlorine-induced killing of Legionella pneumophila (23). 
Long strands of nucleic acids have a greater chance than shorter strands to carry cleavage sites 
for endonucleases. In turn, cleaved strands cannot be amplified by PCR anymore. While DNA 
is very stable in spite of bacterial death (4, 7, 15, 16, 19-21, 28, 29, 34, 36, 37), rRNA may 
behave differently. In the present case, it is possible that antibiotic-induced killing allowed 
non-specific deregulation of bacterial RNases (8, 9), leading to progressive RNA decay. 
Moreover, the kinetics of RNA decay were somewhat delayed as compared to viability loss, 
thus complying with the assumption that RNA degradation was the consequence rather than 
the cause of cell death. 
RNA degradation was not formally demonstrated herein. However, other causes of 
impairment of amplification seem less likely. Secondary structures impeding amplification is 
one alternative, but such structure should not have sustained the PCR conditions. Another 
alternative could involve inhibitors of amplification present only in antibiotic-killed cells. 
However, such inhibitors should also affect amplification of the smaller 119-base interna! 
fragment, which was not the case in these observations. Eventually, the precise limit of RNA 
size useful to diff erentiate between live and dead bacteria was not determined. This size could 
indeed vary between different RNA stretches, and between different bacteria. Nevertheless, 
the experiments described herein provide clear evidence that size must be taken into account. 
Killing of Staphylococcus aureus and E. coli by physical or chemical means indicated 
that 16S rRNA was unstable after autoclaving (24), but was more stable after killing by less 
drastic conditions such as lower temperatures ( 60 or 80°C), ethanol, or UV irradiation (24, 
31 ). In one study (24) the authors used both Northern blotting and reverse-transcription 
followed by non-quantitative PCR to detect rRNA. Fragments length (ca 400-base or larger) 
was not an issue. However, since cDNA was amplified non-quantitatively, the PCR data are 
difficult to interpret. On the other hand, Northern blots clearly indicated a hierarchy of rRNA 
degradation, with total disappearance of rRNA at harsh (120°C) conditions, partial 
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disappearance at less harsh (80°C) conditions, and minimal disappearance after UV 
treatment. It was suggested that the less drastic conditions could respect the physical integrity 
of the ribosomes, thus preventing them from the attack by RNases or other enzymes (24). If 
so, then penicillin and levofloxacin treatments appear doser to harsh than milder conditions. 
Indeed, real-time PCR detected precisely both drug-induced killing and survival of the parent 
S. gordonii and its Toll mutant. 
Eventually, quantitative assessment of rRNA was a better marker of drug~induced 
killing than vital staining. In this particular case, the poor performance of vital stain was due 
to physical alterations of dying bacteria, which became unstainable by the coloration system. 
Although the effect might be more pronounced with cell wall active drugs than other 
compounds, this kind of limit was also reported in other systems, especially when the plasma 
membrane is not physically altered (37). 
Taken together, the present results revive the perspective of using molecular markers 
to detect antibiotic-induced killing of bacteria. They clarify certain differences between 
various reports, and help delineate a molecular system that might detect drug-induced killing. 
An interesting observation was the inverse relationship between rRNA amplification and the 
length of the amplicons. This raises the possibility of combining both short and long 
amplicons in the same assay. Short amplicons would detect both the presence and the nature 
of the organism, while long amplicons would assess its viability. Calculating a ratio between 
the short and long fragments could provide information on the total-over-killed cells both in 
vitro and in clinical samples. 
Molecular tools are increasingly applied for rapid diagnosis, detection of non-
cultivable pathogens and detection of antibiotic-resistance genes. In the future they will also 
include virulence genes such as toxins. Y et, an important limit of current molecular methods 
is that they do not differentiate between live bacteria and dead remnants. The present 
observations indicate that analyzing rRNA fragments could help solve the issue. At this stage 
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the technique using RT-PCR followed by real-time PCR is still too complicated for clinical 
or field application. However, the results identify at least one of the molecular approaèhes that 
might be worth pursuing into engineering development. 
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FIGURE LEGENDS 
Figure 1. Growth (A) and penicillin-induced killing (B) of the parent S. gardon;; (squares) 
and its tolerant mutant Toll (circles) followed by optical density, viable counts and non-
quantitative PCR of 16S rDNA. (A) During growth both optical densities and viable counts 
increased in parallel, while non-quantitative rDNA amplification remained stable. After 
addition of 500x MIC of penicillin G (B) the viable counts decreased sharply in the parent 
strain while remaining stable in the Toll mutant. In contrast, optical densities and rDNA 
densitometries remained steady in both organisms. The experiments were performed in 
triplicate on 3 independent occasions. Inter-experimental variation was .::S 20 %. 
Figure 2. Bacterial growth (A) and penicillin-induced killing (B) followed by viable counts 
and quantitative-PCR 16S rDNA. (A) Both viable counts and numbers of rDNA copies 
increased in parallel and stabilized in the stationary phase (data in panel A are for the parent S. 
gordonii). (B) After penicillin addition viable counts decreased in the parent strain while 
remaining stable in the Toll mutant. Y et, quantitative-PCR of rDNA remained steady in both 
organisms. Details and experimental reproducibility are as in Figure 1. 
Figure 3. Growth and penicillin-induced killing of the S. gordonii parent (A) and penicillin-
induced killing of the Toll mutant (B) followed by viable counts and quantification of a 427-
base fragment of 16S rRNA. In both cases the number of copies of rRNA was proportional to 
the viable counts. The insets at the bottom of the graphs depict crude 23S and 16S rRNA 
prepared from culture aliquots removed at various times during penicillin treatment and 
separated by agarose gel electrophoresis. In the kill-susceptible parent (A) the bands 
disappeared after 24 h of drug treatment. In the kill-resistant Toll mutant (panel B) the bands 
remained visible. Details and experimental reproducibility are as in Figure 1. 
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Figure 4. Bacterial growth and levofloxacin (levo)-induced killing followed by viable 
counts and quantification of either rDNA (A) or rRNA (B). (A) The number of copies of 
rDNA paralleled viable counts during bacterial growth, but remained stable during 
levofloxacin treatment in spite of extensive killing. (B) In contrast, the number of copies of 
rRNA paralleled viable counts both during growth and drug-induced killing. Details and 
experimental reproducibility are as in Figure 1. 
Figure 5. Bacterial growth and penicillin-induced killing of the S. gordonii parent (A) and 
Toll mutant (B) followed by viable counts and quantification of a short (119-base) fragment 
of 16S rRNA. The number of amplified 119-base fragments increased proportionally to viable 
counts during bacterial growth, but did not decrease proportionally do bacterial killing during 
penicillin treatment. Details and experimental reproducibility are as in Figure 1. 
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